| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC3379 |
| Trial ID | NCT05783570 |
| Disease | Hepatocellular Carcinoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | EU307 CAR-T cells |
| Generation | 4th |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | To Evaluate the Safety, Tolerability and Preliminary Efficacy of EU307 |
| Year | 2023 |
| Country | Korea,Republic of |
| Company sponsor | Eutilex |
| Other ID(s) | EU-CTS307-I-01 |
| Cohort 1 | |||||||||
|
|||||||||